about
sameAs
Aspirin and warfarin versus aspirin monotherapy after myocardial infarctionAspirin, warfarin and a thienopyridine for acute coronary syndromesP-selectin inhibition therapeutically promotes thrombus resolution and prevents vein wall fibrosis better than enoxaparin and an inhibitor to von Willebrand factor.Safety and efficacy of targeting platelet proteinase-activated receptors in combination with existing anti-platelet drugs as antithrombotics in miceThromboxane prostanoid receptor stimulation induces shedding of the transmembrane chemokine CX3CL1 yet enhances CX3CL1-dependent leukocyte adhesion.Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil.
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Antithrombotic therapy after myocardial infarction
@ast
Antithrombotic therapy after myocardial infarction
@en
Antithrombotic therapy after myocardial infarction
@nl
type
label
Antithrombotic therapy after myocardial infarction
@ast
Antithrombotic therapy after myocardial infarction
@en
Antithrombotic therapy after myocardial infarction
@nl
prefLabel
Antithrombotic therapy after myocardial infarction
@ast
Antithrombotic therapy after myocardial infarction
@en
Antithrombotic therapy after myocardial infarction
@nl
P356
P1476
Antithrombotic therapy after myocardial infarction
@en
P2093
Richard C Becker
P304
P356
10.1056/NEJME020097
P407
P577
2002-09-26T00:00:00Z